|
|
|
|
| LEADER |
02526nam a2200325 u 4500 |
| 001 |
EB001999719 |
| 003 |
EBX01000000000000001162620 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Wright, Rodney L.
|
| 245 |
0 |
0 |
|a HIV testing during pregnancy, at delivery, and postpartum
|h Elektronische Ressource
|c lead author, Rodney L. Wright ; with the Medical Care Criteria Committee
|
| 260 |
|
|
|a [Baltimore, MD]
|b [Johns Hopkins University]
|c 2020, [July 2020]
|
| 300 |
|
|
|a 1 PDF file (11 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Anti-Retroviral Agents / therapeutic use
|
| 653 |
|
|
|a Pregnancy Complications, Infectious / prevention & control
|
| 653 |
|
|
|a Infectious Disease Transmission, Vertical / prevention & control
|
| 653 |
|
|
|a New York
|
| 653 |
|
|
|a Pregnancy
|
| 653 |
|
|
|a HIV Testing
|
| 653 |
|
|
|a HIV Infections / diagnosis
|
| 710 |
2 |
|
|a New York (State)
|b AIDS Institute
|
| 710 |
2 |
|
|a Clinical Guidelines Program
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 500 |
|
|
|a "This guideline was developed by the NYSDOH AI Clinical Guidelines Program, which is a collaborative effort between the NYSDOH AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases"--PDF page 2
|
| 856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK560463
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Timely diagnosis of HIV and rapid initiation of antiretroviral therapy are crucial to reducing the risk of perinatal HIV transmission and maintaining the health of pregnant patients and their infants. This guideline was developed by the New York State (NYS) Department of Health (DOH) AIDS Institute (AI) to provide evidence-based recommendations regarding HIV testing during pregnancy and at delivery and to promote universal HIV screening for all pregnant patients to achieve the following: Ensure universal HIV screening early in pregnancy, during the third trimester, and during labor for individuals who do not have a documented negative HIV status. Encourage third-trimester testing for syphilis and HIV testing. Encourage HIV testing for pregnant and postpartum patients who exhibit symptoms of acute HIV. Increase uptake of pre-exposure prophylaxis among pregnant patients who do not test positive for HIV but who are at high risk of HIV acquisition during pregnancy and postpartum
|